Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients
Patients with cardiovascular risk factors and a mean cardiac dose greater than 5 Gy are at increased risk of cardiotoxicity and should be referred for Cardio-Oncology evaluation. The application of the CAC score in CT planning could be a valuable screening test that requires further study.
Authors
- Ignasi Gich Saladich
- J. Isern (ORCID: https://orcid.org/0000-0002-0974-3615)
- Gemma Sancho (ORCID: https://orcid.org/0000-0003-2266-6172)
- Pedro Gallego Franco
- Maria Josefa Fuentes Raspall
- N. Jornet Sala
- M. Lizondo Gisbert
- José Simón Martínez-Castañeda (ORCID: https://orcid.org/0000-0002-8727-0307)
- J Cordero
- Eugenia Otero-Pla
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Mútua Terrassa (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.3389/fonc.2025.1552908
- Citations
- 2
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 2.78